Trimethylamine and trimethylamine N-oxide, a Flavin-Containing Monooxygenase 3 (FMO3)-mediated host-microbiome metabolic axis implicated in health and disease

Drug Metabolism and Disposition

Volumn 44, Issue 11, 2016, Pages 1839-1850

  Fennema, Diede ^a   Phillips, Ian R ^a,b   Shephard, Elizabeth A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAINE; CARNITINE; CHOLINE; FLAVIN CONTAINING MONOOXYGENASE 3; THIONEINE; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG; UNSPECIFIC MONOOXYGENASE; DIMETHYLANILINE MONOOXYGENASE (N-OXIDE FORMING); METHYLAMINE; OXYGENASE; TRIMETHYLAMINE; TRIMETHYLOXAMINE;

DIETARY INTAKE; DYSBIOSIS; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME MECHANISM; FIRMICUTES; HOST PATHOGEN INTERACTION; HUMAN; INTESTINE FLORA; MICROBIOME; MOUTH FLORA; NONHUMAN; PROTEOBACTERIA; SHORT SURVEY; TRIMETHYLAMINURIA; VAGINA FLORA; ANIMAL; CARDIOVASCULAR DISEASE; DRUG EFFECTS; METABOLISM;

ANIMALS; CARDIOVASCULAR DISEASES; GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; HUMANS; METHYLAMINES; OXYGENASES;

EID: 85015364857     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.116.070615     Document Type: Short Survey

References (182)

1. Al-Waiz M, Ayesh R, Mitchell SC, Idle JR, and Smith RL (1987c) A genetic polymorphism of the N-oxidation of trimethylamine in humans. Clin Pharmacol Ther 42:588-594.
2. Al-Waiz M, Ayesh R, Mitchell SC, Idle JR, and Smith RL (1989) Trimethylaminuria: the detection of carriers using a trimethylamine load test. J Inherit Metab Dis 12:80-85.
3. Al-Waiz M, Mikov M, Mitchell SC, and Smith RL (1992) The exogenous origin of trimethylamine in the mouse. Metabolism 41:135-136.
4. Al-Waiz M, Mitchell SC, Idle JR, and Smith RL (1987a) The metabolism of 14C-labelled trimethylamine and its N-oxide in man. Xenobiotica 17:551-558.
5. Al-Waiz M, Mitchell SC, Idle JR, and Smith RL (1987b) The relative importance of N-oxidation and N-demethylation in the metabolism of trimethylamine in man. Toxicology 43:117-121.
6. Allerston CK, Shimizu M, Fujieda M, Shephard EA, Yamazaki H, and Phillips IR (2007) Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3). Pharmacogenet Genomics 17:827-839.
7. Andresen PA, Kaasen I, Styrvold OB, Boulnois G, and Strøm AR (1988) Molecular cloning, physical mapping and expression of the bet genes governing the osmoregulatory choline-glycine betaine pathway of Escherichia coli. J Gen Microbiol 134:1737-1746.
8. Anesti V, McDonald IR, Ramaswamy M, Wade WG, Kelly DP, and Wood AP (2005) Isolation and molecular detection of methylotrophic bacteria occurring in the human mouth. Environ Microbiol 7:1227-1238.
9. Armougom F and Raoult D (2009) Exploring microbial diversity using 16S rRNA high-throughput methods. J Comput Sci Syst Biol 2:74-92.
10. Asatoor AM and Simenhoff ML (1965) The origin of urinary dimethylamine. Biochim Biophys Acta 111:384-392.
11. Ayesh R, Mitchell SC, and Smith RL (1995) Dysfunctional N-oxidation of trimethylamine and the influence of testosterone treatment in man. Pharmacogenetics 5:244-246.
12. Ayesh R, Mitchell SC, Zhang A, and Smith RL (1993) The fish odour syndrome: biochemical, familial, and clinical aspects. BMJ 307:655-657.
13. Bain MA, Faull R, Fornasini G, Milne RW, and Evans AM (2006) Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol Dial Transplant 21:1300-1304.
14. Baker FD, Papiska HR, and Campbell LL (1962) Choline fermentation by Desulfovibrio desulfuricans. J Bacteriol 84:973-978.
15. Barrett EL and Kwan HS (1985) Bacterial reduction of trimethylamine oxide. Annu Rev Microbiol 39:131-149.
16. Beatty SA (1938) Studies of Fish Spoilage: II. The origin of trimethylamine produced during the spoilage of cod muscle press juice. J Fish Res Bd Can 4a:63-68.
17. Bennett BJ, de Aguiar Vallim TQ, Wang Z, Shih DM, Meng Y, Gregory J, Allayee H, Lee R, Graham M, Crooke R, et al. (2013) Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab 17:49-60.
18. Boulton CA, Crabbe MJ, and Large PJ (1974) Microbial oxidation of amines. Partial purification of a trimethylamine mono-oxygenase from Pseudomonas aminovorans and its role in growth on trimethylamine. Biochem J 140:253-263.
19. Boutagy NE, Neilson AP, Osterberg KL, Smithson AT, Englund TR, Davy BM, Hulver MW, and Davy KP (2015) Probiotic supplementation and trimethylamine-N-oxide production following a high-fat diet. Obesity (Silver Spring) 23:2357-2363.
20. Bradbeer C (1965) The clostridial fermentations of choline and ethanolamine. 1. Preparation and properties of cell-free extracts. J Biol Chem 240:4669-4674.
21. Brand JM and Galask RP (1986) Trimethylamine: the substance mainly responsible for the fishy odor often associated with bacterial vaginosis. Obstet Gynecol 68:682-685.
22. Brugère J-F, Borrel G, Gaci N, Tottey W, O'Toole PW, and Malpuech-Brugère C (2014) Archaebiotics: proposed therapeutic use of archaea to prevent trimethylaminuria and cardiovascular disease. Gut Microbes 5:5-10.
23. Campbell LL, Jr and Williams OB (1951) The action of members of the genus Achromobacter on trimethylamine oxide and related compounds. J Bacteriol 62:249-251.
24. Caporaso JG, Lauber CL, Costello EK, Berg-Lyons D, Gonzalez A, Stombaugh J, Knights D, Gajer P, Ravel J, Fierer N, et al. (2011) Moving pictures of the human microbiome. Genome Biol 12:R50.
25. Cashman JR (2008) Role of flavin-containing monooxygenase in drug development. Expert Opin Drug Metab Toxicol 4:1507-1521.
26. Cashman JR, Park SB, Berkman CE, and Cashman LE (1995) Role of hepatic flavin-containing monooxygenase 3 in drug and chemical metabolism in adult humans. Chem Biol Interact 96:33-46.
27. Cashman JR, Xiong Y, Lin J, Verhagen H, van Poppel G, van Bladeren PJ, Larsen-Su S, and Williams DE (1999) In vitro and in vivo inhibition of human flavin-containing monooxygenase form 3 (FMO3) in the presence of dietary indoles. Biochem Pharmacol 58:1047-1055.
28. Caspi R, Altman T, Billington R, Dreher K, Foerster H, Fulcher CA, Holland TA, Keseler IM, Kothari A, Kubo A, et al. (2014) The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic Acids Res 42:D459-D471.
29. Chalmers RA, Bain MD, Michelakakis H, Zschocke J, and Iles RA (2006) Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children. J Inherit Metab Dis 29:162-172.
30. Chao CK and Zeisel SH (1990) Formation of trimethylamine from dietary choline by Streptococcus sanguis I, which colonizes the mouth. J Nutr Biochem 1:89-97.
31. Cheah IK and Halliwell B (2012) Ergothioneine; antioxidant potential, physiological function and role in disease. Biochim Biophys Acta 1822:784-793.
32. Chen Y, Patel NA, Crombie A, Scrivens JH, and Murrell JC (2011) Bacterial flavin-containing monooxygenase is trimethylamine monooxygenase. Proc Natl Acad Sci USA 108:17791-17796.
33. Coecke S, Debast G, Phillips IR, Vercruysse A, Shephard EAE, and Rogiers V (1998) Hormonal regulation of microsomal flavin-containing monooxygenase activity by sex steroids and growth hormone in co-cultured adult male rat hepatocytes. Biochem Pharmacol 56:1047-1051.
34. Colby J and Zatman LJ (1973) Trimethylamine metabolism in obligate and facultative methylotrophs. Biochem J 132:101-112.
35. Cox JC and Knight R (1981) Trimethylamine N-oxide (TMAO) reductase activity in chlorate-resistant or respiration-deficient mutants of Escherichia coli. FEMS Microbiol Lett 12:249-252.
36. Cox JC, Madigan MT, Favinger JL, and Gest H (1980) Redox mechanisms in "oxidant-dependent" hexose fermentation by Rhodopseudomonas capsulata. Arch Biochem Biophys 204:10-17.
37. Craciun S and Balskus EP (2012) Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc Natl Acad Sci USA 109:21307-21312.
38. Cruciani G, Valeri A, Goracci L, Pellegrino RM, Buonerba F, and Baroni M (2014) Flavin monooxygenase metabolism: why medicinal chemists should matter. J Med Chem 57:6183-6196.
39. Cruden DL and Galask RP (1988) Reduction of trimethylamine oxide to trimethylamine by Mobiluncus strains isolated from patients with bacterial vaginosis. Microb Ecol Health Dis 1:95-100.
40. Dalgaard P (1995) Qualitative and quantitative characterization of spoilage bacteria from packed fish. Int J Food Microbiol 26:319-333.
41. Denby KJ, Rolfe MD, Crick E, Sanguinetti G, Poole RK, and Green J (2015) Adaptation of anaerobic cultures of Escherichia coli K-12 in response to environmental trimethylamine-N-oxide. Environ Microbiol 17:2477-2491.
42. Ditullio D, Anderson D, Chen CS, and Sih CJ (1994) L-carnitine via enzyme-catalyzed oxidative kinetic resolution. Bioorg Med Chem 2:415-420.
43. Dolphin C, Shephard EA, Povey S, Palmer CN, Ziegler DM, Ayesh R, Smith RL, and Phillips IR (1991) Cloning, primary sequence, and chromosomal mapping of a human flavin-containing monooxygenase (FMO1). J Biol Chem 266:12379-12385.
44. Dolphin CT, Cullingford TE, Shephard EA, Smith RL, and Phillips IR (1996) Differential developmental and tissue-specific regulation of expression of the genes encoding three members of the flavin-containing monooxygenase family of man, FMO1, FMO3 and FM04. Eur J Biochem 235:683-689.
45. Dolphin CT, Janmohamed A, Smith RL, Shephard EA, and Phillips IR (1997) Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome. Nat Genet 17:491-494.
46. Dolphin CT, Janmohamed A, Smith RL, Shephard EA, and Phillips IR (2000) Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FM03) gene in patients with fish-odour syndrome. Pharmacogenetics 10:799-807.
47. Easter MC, Gibson DM, and Ward FB (1982) A conductance method for the assay and study of bacterial trimethylamine oxide reduction. J Appl Bacteriol 52:357-365.
48. Easter MC, Gibson DM, and Ward FB (1983) The induction and location of trimethylamine-N-oxide reductase in Alteromonas sp. NCMB 400. Microbiology 129:3689-3696.
49. Eddy BP (1953) Bacterial degradation of choline. Nature 171:573-574.
50. Ey J, Schömig E, and Taubert D (2007) Dietary sources and antioxidant effects of ergothioneine. J Agric Food Chem 55:6466-6474.
51. Falls JG, Blake BL, Cao Y, Levi PE, and Hodgson E (1995) Gender differences in hepatic expression of flavin-containing monooxygenase isoforms (FMO1, FMO3, and FMO5) in mice. J Biochem Toxicol 10:171-177.
52. Feller AG and Rudman D (1988) Role of carnitine in human nutrition. J Nutr 118:541-547.
53. Fiebig K and Gottschalk G (1983) Methanogenesis from choline by a coculture of Desulfovibrio sp. and Methanosarcina barkeri. Appl Environ Microbiol 45:161-168.
54. Flanagan JL, Simmons PA, Vehige J, Willcox MD, and Garrett Q (2010) Role of carnitine in disease. Nutr Metab (Lond) 7:30.
55. Fukami K, Yamagishi S, Sakai K, Kaida Y, Yokoro M, Ueda S, Wada Y, Takeuchi M, Shimizu M, Yamazaki H, et al. (2015) Oral L-carnitine supplementation increases trimethylamine-N-oxide but reduces markers of vascular injury in hemodialysis patients. J Cardiovasc Pharmacol 65:289-295.
56. Gao X, Liu X, Xu J, Xue C, Xue Y, and Wang Y (2014) Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet. J Biosci Bioeng 118:476-481.
57. Gonzalez Malagon SG, Melidoni AN, Hernandez D, Omar BA, Houseman L, Veeravalli S, Scott F, Varshavi D, Everett J, Tsuchiya Y, et al. (2015) The phenotype of a knockout mouse identifies flavin-containing monooxygenase 5 (FMO5) as a regulator of metabolic ageing. Biochem Pharmacol 96:267-277.
58. Gut I and Conney AH (1991) The FAD-containing monooxygenase-catalyzed N-oxidation and demethylation of trimethylamine in rat liver microsomes. Drug Metabol Drug Interact 9:201-208.
59. Gut I and Conney AH (1993) Trimethylamine N-oxygenation and N-demethylation in rat liver microsomes. Biochem Pharmacol 46:239-244.
60. Hao X, Liu X, Wang W, Ren H, Xie J, Shen P, Lin D, and Chen N (2013) Distinct metabolic profile of primary focal segmental glomerulosclerosis revealed by NMR-based metabolomics. PLoS One 8:e78531.
61. Hayward HR and Stadtman TC (1959) Anaerobic degradation of choline. I. Fermentation of choline by an anaerobic, cytochrome-producing bacterium, Vibrio cholinicus n. sp. J Bacteriol 78:557-561.
62. Hayward HR and Stadtman TC (1960) Anaerobic degradation of choline. II. Preparation and properties of cell-free extracts of Vibrio cholinicus. J Biol Chem 235:538-543.
63. Heijthuijsen JH and Hansen TA (1989) Betaine fermentation and oxidation by marine desulfuromonas strains. Appl Environ Microbiol 55:965-969.
64. Hernandez D, Addou S, Lee D, Orengo C, Shephard EA, and Phillips IR (2003) Trimethylaminuria and a human FMO3 mutation database. Hum Mutat 22:209-213.
65. Hernandez D, Janmohamed A, Chandan P, Phillips IR, and Shephard EA (2004) Organization and evolution of the flavin-containing monooxygenase genes of human and mouse: identification of novel gene and pseudogene clusters. Pharmacogenetics 14:117-130.
66. Higgins T, Chaykin S, Hammond KB, and Humbert JR (1972) Trimethylamine N-oxide synthesis: a human variant. Biochem Med 6:392-396.
67. Hirsch MJ, Growdon JH, and Wurtman RJ (1978) Relations between dietary choline or lecithin intake, serum choline levels, and various metabolic indices. Metabolism 27:953-960.
68. Holmes HC, Burns SP, Michelakakis H, Kordoni V, Bain MD, Chalmers RA, Rafter JE, and Iles RA (1997) Choline and L-carnitine as precursors of trimethylamine. Biochem Soc Trans 25:96S.
69. Hormann K and Andreesen JR (1989) Reductive cleavage of sarcosine and betaine by Eubacterium acidaminophilum via enzyme systems different from glycine reductase. Arch Microbiol 153:50-59.
70. Hur E, Gungor O, Bozkurt D, Bozgul S, Dusunur F, Caliskan H, Berdeli A, Akcicek F, Basci A, and Duman S (2012) Trimethylaminuria (fish malodour syndrome) in chronic renal failure. Hippokratia 16:83-85.
71. Hyman RW, Fukushima M, Diamond L, Kumm J, Giudice LC, and Davis RW (2005) Microbes on the human vaginal epithelium. Proc Natl Acad Sci USA 102:7952-7957.
72. Ishimoto M and Shimokawa O (1978) Reduction of trimethylamine N-oxide by Escherichia coli as anaerobic respiration. Z Allg Mikrobiol 18:173-181.
73. Janmohamed A, Dolphin CT, Phillips IR, and Shephard EA (2001) Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450. Biochem Pharmacol 62:777-786.
74. Janmohamed A, Hernandez D, Phillips IR, and Shephard EA (2004) Cell-, tissue-, sex- and developmental stage-specific expression of mouse flavin-containing monooxygenases (Fmos). Biochem Pharmacol 68:73-83.
75. Kalnins G, Kuka J, Grinberga S, Makrecka-Kuka M, Liepinsh E, Dambrova M, and Tars K (2015) Structure and fubction of CutC choline lyase from human microbiota bacterium Klebsiella pneumonia. J Biol Chem 290:21732-21740.
76. Kelly B and Appleman MD (1961) Degradation of ergothioneine by cell-free extracts of Alcaligenes faecalis. J Bacteriol 81:715-720.
77. Kleber H-P (1997) Bacterial carnitine metabolism. FEMS Microbiol Lett 147:1-9.
78. Kleber H-P, Seim H, Aurich H, and Strack E (1977) [Utilization of trimethylammonium-compounds by Acinetobacter calcoaceticus (author's transl)]. Arch Microbiol 112:201-206.
79. Kleber H-P, Seim H, Aurich H, and Strack E (1978) [Interrelationships between carnitine metabolism and fatty acid assimilation in Pseudomonas putida (author's transl)]. Arch Microbiol 116:213-220.
80. Koeth RA, Levison BS, Culley MK, Buffa JA, Wang Z, Gregory JC, Org E, Wu Y, Li L, Smith JD, et al. (2014) γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. Cell Metab 20:799-812.
81. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, et al. (2013) Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19:576-585.
82. Koukouritaki SB, Poch MT, Cabacungan ET, McCarver DG, and Hines RN (2005) Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variants. Mol Pharmacol 68:383-392.
83. Koukouritaki SB, Simpson P, Yeung CK, Rettie AE, and Hines RN (2002) Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression. Pediatr Res 51:236-243.
84. Krueger SK and Williams DE (2005) Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther 106:357-387.
85. Kuka J, Liepinsh E, Makrecka-Kuka M, Liepins J, Cirule H, Gustina D, Loza E, Zharkova-Malkova O, Grinberga S, Pugovics O, et al. (2014) Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation. Life Sci 117:84-92.
86. Kwan HS and Barrett EL (1983) Purification and properties of trimethylamine oxide reductase from Salmonella typhimurium. J Bacteriol 155:1455-1458.
87. Lang DH, Yeung CK, Peter RM, Ibarra C, Gasser R, Itagaki K, Philpot RM, and Rettie AE (1998) Isoform specificity of trimethylamine N-oxygenation by human flavin-containing monooxygenase (FMO) and P450 enzymes: selective catalysis by FMO3. Biochem Pharmacol 56:1005-1012.
88. Large PJ, Boulton CA, and Crabbe MJ (1972) The reduced nicotinamide-adenine dinucleotide phosphate- and oxygen-dependent N-oxygenation of trimethylamine by Pseudomonas aminovorans. Biochem J 128:137P-138P.
89. Lattard V, Zhang J, Tran Q, Furnes B, Schlenk D, and Cashman JR (2003) Two new polymorphisms of the FMO3 gene in Caucasian and African-American populations: comparative genetic and functional studies. Drug Metab Dispos 31:854-860.
90. Lee JV, Gibson DM, and Shewan JM (1977) A numerical taxonomic study of some Pseudomonas-like marine bacteria. J Gen Microbiol 98:439-451.
91. Lerke P, Adams R, and Farber L (1965) Bacteriology of spoilage of fish muscle. 3. Characterization of spoilers. Appl Microbiol 13:625-630.
92. Ley RE, Turnbaugh PJ, Klein S, and Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444:1022-1023.
93. Lin JK and Hurng DC (1989) Potentiation of ferrous sulphate and ascorbate on the microbial transformation of endogenous trimethylamine N-oxide to trimethylamine and dimethylamine in squid extracts. Food Chem Toxicol 27:613-618.
94. 2 concentrations. Int J Food Microbiol 64:277-287.
95. 2 as the energy source. J Bacteriol 137:524-530.
96. Madigan MT, Cox JC, and Gest H (1980) Physiology of dark fermentative growth of Rhodopseudomonas capsulata. J Bacteriol 142:908-915.
97. Martínez-del Campo A, Bodea S, Hamer HA, Marks JA, Haiser HJ, Turnbaugh PJ, and Balskus EP (2015) Characterization and detection of a widely distributed gene cluster that predicts anaerobic choline utilization by human gut bacteria. MBio 6:e00042-15.
98. Mayatepek E, Flock B, and Zschocke J (2004) Benzydamine metabolism in vivo is impaired in patients with deficiency of flavin-containing monooxygenase 3. Pharmacogenetics 14:775-777.
99. Meadows JA and Wargo MJ (2015) Carnitine in bacterial physiology and metabolism. Microbiology 161:1161-1174.
100. Meiberg JBM, Bruinenberg PM, and Harder W (1980) Effect of dissolved oxygen tension on the metabolism of methylated amines in Hyphomicrobium X in the absence and presence of nitrate: Evidence for "aerobic" denitrification. Microbiol 120:453-463.
101. Miao J, Ling AV, Manthena PV, Gearing ME, Graham MJ, Crooke RM, Croce KJ, Esquejo RM, Clish CB, Vicent D, et al.; Morbid Obesity Study Group (2015) Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nat Commun 6:6498.
102. Miller CA, Corbin KD, da Costa K-A, Zhang S, Zhao X, Galanko JA, Blevins T, Bennett BJ, O'Connor A, and Zeisel SH (2014) Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study. Am J Clin Nutr 100:778-786.
103. Mitchell S, Ayesh R, Barrett T, and Smith R (1999) Trimethylamine and foetor hepaticus. Scand J Gastroenterol 34:524-528.
104. Mitchell SC (2005) Trimethylaminuria (fish-odour syndrome) and oral malodour. Oral Dis 11 (Suppl 1):10-13.
105. Mitchell SC and Smith RL (2001) Trimethylaminuria: the fish malodor syndrome. Drug Metab Dispos 29:517-521.
106. Mitchell SC and Smith RL (2010) A physiological role for flavin-containing monooxygenase (FMO3) in humans? Xenobiotica 40:301-305.
107. Mitchell SC and Smith RL (2016) Trimethylamine-the extracorporeal envoy. Chem Senses 41:275-279.
108. Mitchell SC, Zhang AQ, and Smith RL (2002) Chemical and biological liberation of trimethylamine from foods. J Food Compos Anal 15:277-282.
109. Miura-Fraboni J, Kleber H-P, and Englard S (1982) Assimilation of γ-butyrobetaine, and D-and L-carnitine by resting cell suspensions of Acinetobacter calcoaceticus and Pseudomonas putida. Arch Microbiol 133:217-221.
110. Mouné S, Manac'h N, Hirschler A, Caumette P, Willison JC, and Matheron R (1999) Haloanaerobacter salinarius sp. nov., a novel halophilic fermentative bacterium that reduces glycine-betaine to trimethylamine with hydrogen or serine as electron donors; emendation of the genus Haloanaerobacter. Int J Syst Bacteriol 49:103-112.
111. Möller B, Hippe H, and Gottschalk G (1986) Degradation of various amine compounds by mesophilic clostridia. Arch Microbiol 145:85-90.
112. Muramatsu H, Matsuo H, Okada N, Ueda M, Yamamoto H, Kato S, and Nagata S (2013) Characterization of ergothionase from Burkholderia sp. HME13 and its application to enzymatic quantification of ergothioneine. Appl Microbiol Biotechnol 97:5389-5400.
113. Mushiroda T, Douya R, Takahara E, and Nagata O (2000) The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate. Drug Metab Dispos 28:1231-1237.
114. Myers PA and Zatman LJ (1971) The metabolism of trimethylamine N-oxide by Bacillus PM6. Biochem J 121:10P.
115. Naumann E, Hippe H, and Gottschalk G (1983) Betaine: New oxidant in the Stickland reaction and methanogenesis from betaine and l-alanine by a Clostridium sporogenes-Methanosarcina barkeri coculture. Appl Environ Microbiol 45:474-483.
116. Navaneethan U, Parsi MA, Gutierrez NG, Bhatt A, Venkatesh PGK, Lourdusamy D, Grove D, Hammel JP, Jang S, Sanaka MR, et al. (2014) Volatile organic compounds in bile can diagnose malignant biliary strictures in the setting of pancreatic cancer: a preliminary observation. Gastrointest Endosc 80:1038-1045.
117. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, and Pettersson S (2012) Host-gut microbiota metabolic interactions. Science 336:1262-1267.
118. Oakley BB, Fiedler TL, Marrazzo JM, and Fredricks DN (2008) Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol 74:4898-4909.
119. Obeid R (2013) The metabolic burden of methyl donor deficiency with focus on the betaine homocysteine methyltransferase pathway. Nutrients 5:3481-3495.
120. Obeid R, Awwad HM, Rabagny Y, Graeber S, Herrmann W, and Geisel J (2016) Plasma trimethylamine N-oxide concentration is associated with choline, phospholipids, and methyl metabolism. Am J Clin Nutr 103:703-711.
121. Pang PKT, Griffith RW, and Atz JW (1977) Osmoregulation in elasmobranchs. Am Zool 17:365-377.
122. Parte P and Kupfer D (2005) Oxidation of tamoxifen by human flavin-containing monooxygenase (FMO) 1 and FMO3 to tamoxifen-N-oxide and its novel reduction back to tamoxifen by human cytochromes P450 and hemoglobin. Drug Metab Dispos 33:1446-1452.
123. Pfeiffer C, Bauer T, Surek B, Schömig E, and Gründemann D (2011) Cyanobacteria produce high levels of ergothioneine. Food Chem 129:1766-1769.
124. Phillips IR, Dolphin CT, Clair P, Hadley MR, Hutt AJ, McCombie RR, Smith RL, and Shephard EA (1995) The molecular biology of the flavin-containing monooxygenases of man. Chem Biol Interact 96:17-32.
125. Phillips IR, Francois AA, and Shephard EA (2007) The flavin-containing monooxygenases (FMOs): genetic variation and its consequences for the metabolism of therapeutic drugs. Curr Pharmacogenomics 5:292-313.
126. Phillips IR and Shephard EA (2008) Flavin-containing monooxygenases: mutations, disease and drug response. Trends Pharmacol Sci 29:294-301.
127. Rebouche CJ and Chenard CA (1991) Metabolic fate of dietary carnitine in human adults: identification and quantification of urinary and fecal metabolites. J Nutr 121:539-546.
128. Rebouche CJ and Seim H (1998) Carnitine metabolism and its regulation in microorganisms and mammals. Annu Rev Nutr 18:39-61.
129. Ringø E, Stenberg E, and Strøm AR (1984) Amino acid and lactate catabolism in trimethylamine oxide respiration of Alteromonas putrefaciens NCMB 1735. Appl Environ Microbiol 47:1084-1089.
130. Robinson J, Gibbons NE, and Thatcher FS (1952) A mechanism of halophilism in Micrococcus halodenitrificans. J Bacteriol 64:69-77.
131. Romano KA, Vivas EI, Amador-Noguez D, and Rey FE (2015) Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio 6:e02481.
132. Scully C and Greenman J (2012) Halitology (breath odour: aetiopathogenesis and management). Oral Dis 18:333-345.
133. Seebeck FP (2010) In vitro reconstitution of Mycobacterial ergothioneine biosynthesis. J Am Chem Soc 132:6632-6633.
134. Seim H, Löster H, Claus R, Kleber H-P, and Strack E (1982a) Formation of γ-butyrobetaine and trimethylamine from quaternary ammonium compounds structure-related to L-carnitine and choline by Proteus vulgaris. FEMS Microbiol Lett 13:201-205.
135. Seim H, Löster H, Claus R, Kleber H-P, and Strack E (1982b) Splitting of the C-N bond in carnitine by an enzyme (trimethylamine forming) from membranes of Acinetobacter calcoaceticus. FEMS Microbiol Lett 15:165-167.
136. Seim H, Schulze J, and Strack E (1985) Catabolic pathways for high-dosed L(-)- or D(+)-carnitine in germ-free rats? Biol Chem Hoppe Seyler 366:1017-1021.
137. Sellars MJ, Hall SJ, and Kelly DJ (2002) Growth of Campylobacter jejuni supported by respiration of fumarate, nitrate, nitrite, trimethylamine-N-oxide, or dimethyl sulfoxide requires oxygen. J Bacteriol 184:4187-4196.
138. Serra AL, Mariscotti JF, Barra JL, Lucchesi GI, Domenech CE, and Lisa AT (2002) Glycine betaine transmethylase mutant of Pseudomonas aeruginosa. J Bacteriol 184:4301-4303.
139. Shaw BG and Shewan JM (1968) Psychrophilic spoilage bacteria of fish. J Appl Bacteriol 31: 89-96.
140. Shephard EA, Treacy EP, and Phillips IR (2015) Clinical utility gene card for: Trimethylaminuria - update 2014. Eur J Hum Genet DOI: 10.1038/ejhg.2014.226.
141. Shih DM, Wang Z, Lee R, Meng Y, Che N, Charugundla S, Qi H, Wu J, Pan C, Brown JM, et al. (2015) Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis. J Lipid Res 56:22-37.
142. Shimizu M, Allerston CK, Shephard EA, Yamazaki H, and Phillips IR (2014) Relationships between flavin-containing mono-oxygenase 3 (FMO3) genotype and trimethylaminuria phenotype in a Japanese population. Br J Clin Pharmacol 77:839-851.
143. Simenhoff ML, Saukkonen JJ, Burke JF, Wesson LG, and Schaedler RW (1976) Amine metabolism and the small bowel in uraemia. Lancet 2:818-821.
144. Söderberg MM, Haslemo T, Molden E, and Dahl M-L (2013) Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric patients. Pharmacogenomics J 13:544-550.
145. Stenberg E, Styrvold OB, and Strøm AR (1982) Trimethylamine oxide respiration in Proteus sp. strain NTHC153: electron transfer-dependent phosphorylation and L-serine transport. J Bacteriol 149:22-28.
146. Strøm AR, Olafsen JA, and Larsen H (1979) Trimethylamine oxide: a terminal electron acceptor in anaerobic respiration of bacteria. J Gen Microbiol 112:315-320.
147. Takagi M, Tsuchiya T, and Ishimoto M (1981) Proton translocation coupled to trimethylamine N-oxide reduction in anaerobically grown Escherichia coli. J Bacteriol 148:762-768.
148. Takata Y, Zhang X, Li H, Gao Y-T, Yang G, Gao J, Cai H, Xiang Y-B, Zheng W, and Shu X-O (2013) Fish intake and risks of total and cause-specific mortality in 2 population-based cohort studies of 134,296 men and women. Am J Epidemiol 178:46-57.
149. Tang WHW, Wang Z, Kennedy DJ, Wu Y, Buffa JA, Agatisa-Boyle B, Li XS, Levison BS, and Hazen SL (2015) Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ Res 116:448-455.
150. Tang WHW, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, and Hazen SL (2013) Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 368:1575-1584.
151. Tottey W, Denonfoux J, Jaziri F, Parisot N, Missaoui M, Hill D, Borrel G, Peyretaillade E, Alric M, Harris HMB, et al. (2013) The human gut chip "HuGChip", an explorative phylogenetic microarray for determining gut microbiome diversity at family level. PLoS One 8:e62544.
152. Treacy EP, Akerman BR, Chow LML, Youil R, Bibeau C, Lin J, Bruce AG, Knight M, Danks DM, Cashman JR, et al. (1998) Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication. Hum Mol Genet 7:839-845.
153. Ufnal M, Zadlo A, and Ostaszewski R (2015) TMAO: A small molecule of great expectations. Nutrition 31:1317-1323.
154. Unemoto T, Hayashi M, Miyaki K, and Hayashi M (1965) Intracellular localization and properties of trimethylamine-N-oxide reductase in Vibrio parahaemolyticus. Biochim Biophys Acta 110:319-328.
155. Unemoto T, Hayashi M, Miyaki K, and Hayashi M (1966) Formation of trimethylamine from DL-carnitine by Serratia marcescens. Biochim Biophys Acta 121:220-222.
156. Walker V and Wevers RA (2012) Trimethylaminuria and dimethylglycine dehydrogenase deficiency, in Inborn Metabolic Diseases (Saudubray J-M, van den Berghe G, and Walker JH, eds) pp 431-435, Springer, Berlin, Germany.
157. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung Y-M, et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472:57-63.
158. Wang Z, Roberts AB, Buffa JA, Levison BS, Zhu W, Org E, Gu X, Huang Y, Zamanian-Daryoush M, Culley MK, et al. (2015) Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis. Cell 163:1585-1595.
159. Warrier M, Shih DM, Burrows AC, Ferguson D, Gromovsky AD, Brown AL, Marshall S, McDaniel A, Schugar RC, Wang Z, et al. (2015) The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance. Cell Reports 10:326-338.
160. Wilson A, Teft WA, Morse BL, Choi Y-H, Woolsey S, DeGorter MK, Hegele RA, Tirona RG, and Kim RB (2015) Trimethylamine-N-oxide: A novel biomarker for the identification of inflammatory bowel disease. Dig Dis Sci 60:3620-3630.
161. Wise PM, Eades J, Tjoa S, Fennessey PV, and Preti G (2011) Individuals reporting idiopathic malodor production: demographics and incidence of trimethylaminuria. Am J Med 124:1058-1063.
162. Wolff JB (1962) Ergothionase from Escherichia coli. J Biol Chem 237:874-881.
163. Wolrath H, Borén H, Hallén A, and Forsum U (2002) Trimethylamine content in vaginal secretion and its relation to bacterial vaginosis. APMIS 110:819-824.
164. Wood AJ, Baird EA, and Keeping FE (1943) A primary division of the genus Shigella based on the trimethylamine test. J Bacteriol 46:106-107.
165. Wood AJ and Keeping FE (1944) The formation of trimethylamine from choline as a characteristic of Shigella alkalescens. J Bacteriol 47:309-310.
166. Wood AP, Warren FJ, and Kelly DP (2010) Methylotrophic bacteria in trimethylaminuria and bacterial vaginosis, in Handbook of Hydrocarbon and Lipid Microbiology (Timmis KN, McGenity TJ, van der Meer JR, and de Lorenzo V, eds) pp 3227-3240, Springer, Berlin, Germany.
167. Xu R, Wang Q, and Li L (2015) A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat. BMC Genomics 16 (Suppl 7):S4.
168. Yamazaki H and Shimizu M (2013) Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activities. Biochem Pharmacol 85:1588-1593.
169. Yanasugondha D and Appleman MD (1957) Degradation of ergothioneine by Alcaligenes faecalis. J Bacteriol 74:381-385.
170. Yang Y, Liu Y, Zheng L, Wu T, Li J, Zhang Q, Li X, Yuan F, Wang L, and Guo J (2014) Serum metabonomic analysis of apoE(-/-) mice reveals progression axes for atherosclerosis based on NMR spectroscopy. Mol Biosyst 10:3170-3178.
171. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, et al. (2012) Human gut microbiome viewed across age and geography. Nature 486:222-227.
172. Zeisel SH (1990) Choline deficiency. J Nutr Biochem 1:332-349.
173. Zeisel SH, daCosta KA, Youssef M, and Hensey S (1989) Conversion of dietary choline to trimethylamine and dimethylamine in rats: dose-response relationship. J Nutr 119:800-804.
174. Zeisel SH, Mar M-H, Howe JC, and Holden JM (2003) Concentrations of choline-containing compounds and betaine in common foods. JNutr133:1302-1307.
175. Zeisel SH, Wishnok JS, and Blusztajn JK (1983) Formation of methylamines from ingested choline and lecithin. J Pharmacol Exp Ther 225:320-324.
176. Zerbst-Boroffka I, Kamaltynow RM, Harjes S, Kinne-Saffran E, and Gross J (2005) TMAO and other organic osmolytes in the muscles of amphipods (Crustacea) from shallow and deep water of Lake Baikal. Comp Biochem Physiol A Mol Integr Physiol 142:58-64.
177. Zhang AQ, Mitchell SC, and Smith RL (1999) Dietary precursors of trimethylamine in man: a pilot study. Food Chem Toxicol 37:515-520.
178. Zhou L-P, Tan Z-R, Chen H, Guo D, Chen Y, Huang W-H, Wang L-S, and Zhang G-G (2014) Effect of two-linked mutations of the FMO3 gene on itopride metabolism in Chinese healthy volunteers. Eur J Clin Pharmacol 70:1333-1338.
179. Zhu Y, Jameson E, Crosatti M, Schäfer H, Rajakumar K, Bugg TDH, and Chen Y (2014) Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota. Proc Natl Acad Sci USA 111:4268-4273.
180. Zindel U, Freudenberg W, Rieth M, Andreesen JR, Schnell J, and Widdel F (1988) Eubacterium acidaminophilum sp. nov., a versatile amino acid-degrading anaerobe producing or utilizing H2 or formate. Arch Microbiol 150:254-266.
181. Zoetendal EG, Rajilic-Stojanovic M, and de Vos WM (2008) High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57:1605-1615.
182. Zschocke J and Mayatepek E (2000) Biochemical and molecular studies in mild flavin monooxygenase 3 deficiency. J Inherit Metab Dis 23:378-382.